Results of the procurement procedure
Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.4)Type of the contracting authorityEuropean institution/agency or international organisation
I.5)Main activityGeneral public services
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Study on the impact of mergers and acquisitions on innovation in the pharmaceutical sector
Reference number: 2017/RTD/E.1/OP/PP-06021-2017
II.1.2)Main CPV code73110000 Research services
II.1.3)Type of contractServices
II.1.4)Short description:
This study will aim at better understanding the impacts of mergers on innovation within the pharma sector. The contractor will analyse at least 100 M&A cases from the period 2010-2013, looking at how different indicators evolve from 3-4 years before merger until 3-4 years post-merger. Going beyond previous academic works they will not only analyse R&D investment/intensity and patents but indicators such as:
— number of drug candidates in various clinical development phases,
— progress in pipeline,
— number of discontinued programmes in view of related clinical trial results,
— market entry of new products.
II.1.6)Information about lotsThis contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)Value excluding VAT: 277 800.00 EUR
II.2)Description
II.2.3)Place of performanceNUTS code: BE BELGIQUE-BELGIË
Main site or place of performance:
Mainly at the premises of the contractor.
II.2.4)Description of the procurement:
See internet address provided in section I.3.
II.2.5)Award criteriaQuality criterion - Name: Quality of the proposed methodology / Weighting: 70 points
Quality criterion - Name: Organisation of the work and resources / Weighting: 20 points
Quality criterion - Name: Quality control measures / Weighting: 10 points
Price - Weighting: 40
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: yes
Identification of the project: Horizon 2020
II.2.14)Additional information
See internet address provided in section I.3.
Section IV: Procedure
IV.1)Description
IV.1.1)Type of procedureOpen procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice
Section V: Award of contract
Title:
Study on the impact of mergers and acquisitions on innovation in the pharmaceutical sector
A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:11/01/2018
V.2.2)Information about tendersNumber of tenders received: 14
Number of tenders received from SMEs: 6
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 0
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractorOfficial name: Informa Pharma Consulting
Postal address: Christchurch Court, 10-15 Newgate Street
Town: London
NUTS code: UK UNITED KINGDOM
Postal code: EC1A 7AZ
Country: United Kingdom
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)Total value of the contract/lot: 277 800.00 EUR
V.2.5)Information about subcontracting
Section VI: Complementary information
VI.3)Additional information:
VI.4)Procedures for review
VI.4.3)Review procedurePrecise information on deadline(s) for review procedures:
See internet address provided in section I.3.
VI.5)Date of dispatch of this notice:31/01/2018